CAMBRIDGE, Mass., June 26, 2018 — Skyhawk Therapeutics, Inc. (“Skyhawk”), today announced the closing of a new $40 million equity investment round alongside its recently announced $60 million strategic collaboration, bringing total new capital into the company to over $100 million. Proceeds will be used for development of Skyhawk’s innovative STAR* technology platform to discover and develop small molecules that correct mutations in … Continue reading Skyhawk Therapeutics Announces $40 Million Equity Investment Round